Globus Medical Inc (GMED) stock
GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$69.99−0.51 (-0.72%)
Close on Nov 17, 2026Market cap $9.40BP/E 17.9Yield –
Globus Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Globus Medical's gross margin for the twelve months ending Jun 30, 2026 was 68.5%. For fiscal 2025 it was 67.4%, against 58.9% the year before. The highest annual figure on record is 81.3% in fiscal 2010.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 67.4% | +8.5 |
| FY2024 | Dec 31, 2024 | 58.9% | −6.2 |
| FY2023 | Dec 31, 2023 | 65.1% | −9.2 |
| FY2022 | Dec 31, 2022 | 74.2% | −0.8 |
| FY2021 | Dec 31, 2021 | 75.0% | +2.6 |
| FY2020 | Dec 31, 2020 | 72.4% | −4.6 |
| FY2019 | Dec 31, 2019 | 77.1% | −0.6 |
| FY2018 | Dec 31, 2018 | 77.6% | +1.3 |
| FY2017 | Dec 31, 2017 | 76.3% | +0.2 |
| FY2016 | Dec 31, 2016 | 76.1% | +0.4 |
| FY2015 | Dec 31, 2015 | 75.7% | −0.9 |
| FY2014 | Dec 31, 2014 | 76.6% | −0.3 |
| FY2013 | Dec 31, 2013 | 76.9% | −3.6 |
| FY2012 | Dec 31, 2012 | 80.5% | +1.3 |
| FY2011 | Dec 31, 2011 | 79.2% | −2.1 |
| FY2010 | Dec 31, 2010 | 81.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 69.4% | +2.8 |
| Q1 FY2026 | Mar 31, 2026 | 69.2% | +1.9 |
| Q4 FY2025 | Dec 31, 2025 | 68.4% | +8.5 |
| Q3 FY2025 | Sep 30, 2025 | 67.2% | +10.4 |
| Q2 FY2025 | Jun 30, 2025 | 66.6% | +7.9 |
| Q1 FY2025 | Mar 31, 2025 | 67.3% | +7.1 |
| Q4 FY2024 | Dec 31, 2024 | 59.9% | +3.0 |
| Q3 FY2024 | Sep 30, 2024 | 56.8% | −7.9 |
| Q2 FY2024 | Jun 30, 2024 | 58.7% | −15.1 |
| Q1 FY2024 | Mar 31, 2024 | 60.2% | −14.2 |
| Q4 FY2023 | Dec 31, 2023 | 56.9% | −17.3 |
| Q3 FY2023 | Sep 30, 2023 | 64.7% | −9.5 |
| Q2 FY2023 | Jun 30, 2023 | 73.8% | −0.3 |
| Q1 FY2023 | Mar 31, 2023 | 74.4% | +0.1 |
| Q4 FY2022 | Dec 31, 2022 | 74.3% | −1.0 |
| Q3 FY2022 | Sep 30, 2022 | 74.2% | −0.3 |
| Q2 FY2022 | Jun 30, 2022 | 74.0% | −0.5 |
| Q1 FY2022 | Mar 31, 2022 | 74.3% | −1.5 |
| Q4 FY2021 | Dec 31, 2021 | 75.3% | +1.4 |
| Q3 FY2021 | Sep 30, 2021 | 74.5% | +0.9 |
| Q2 FY2021 | Jun 30, 2021 | 74.6% | +8.6 |
| Q1 FY2021 | Mar 31, 2021 | 75.8% | +1.4 |
| Q4 FY2020 | Dec 31, 2020 | 73.9% | −3.0 |
| Q3 FY2020 | Sep 30, 2020 | 73.6% | −3.3 |
| Q2 FY2020 | Jun 30, 2020 | 66.0% | −11.4 |
| Q1 FY2020 | Mar 31, 2020 | 74.4% | −2.8 |
| Q4 FY2019 | Dec 31, 2019 | 77.0% | +0.4 |
| Q3 FY2019 | Sep 30, 2019 | 76.9% | −0.8 |
| Q2 FY2019 | Jun 30, 2019 | 77.4% | −0.9 |
| Q1 FY2019 | Mar 31, 2019 | 77.1% | −1.1 |
| Q4 FY2018 | Dec 31, 2018 | 76.5% | −0.2 |
| Q3 FY2018 | Sep 30, 2018 | 77.6% | +1.9 |
| Q2 FY2018 | Jun 30, 2018 | 78.3% | +2.7 |
| Q1 FY2018 | Mar 31, 2018 | 78.2% | +1.1 |
| Q4 FY2017 | Dec 31, 2017 | 76.8% | +2.5 |
| Q3 FY2017 | Sep 30, 2017 | 75.7% | −1.1 |
| Q2 FY2017 | Jun 30, 2017 | 75.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 77.2% | – |
| Q4 FY2016 | Dec 31, 2016 | 74.3% | – |
| Q3 FY2016 | Sep 30, 2016 | 76.8% | – |
See a number that looks wrong?